文献速递糖尿病

儿童身高增长率与胰岛自身免疫风险及1型糖尿病发病的关系

Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该前瞻性队列纳入芬兰、德国、瑞典和美国10145名1–8岁儿童,分析儿童期身高增长与胰岛自身免疫出现及进展为1型糖尿病的关系。身高快速增长与胰岛自身免疫血清转换风险升高相关(1–3岁HR=1.26,>3岁HR=1.48),并与从胰岛素自身抗体血清转换进展为1型糖尿病正相关(HR=1.80)。

要点

  • 儿童期身高快速增长与胰岛自身免疫血清转换风险升高相关。
  • 1–3岁HR=1.26(95%CI 1.05,1.51),>3岁HR=1.48(95%CI 1.28,1.73)。
  • 从胰岛素自身抗体血清转换至1型糖尿病,身高增长率正相关(HR=1.80)。

核心结论

  • 儿童期身高快速增长与胰岛自身免疫风险升高及进展为1型糖尿病相关。
  • 需要进一步研究以探讨可能解释该关联的生物学机制。

研究设计与样本

  • 前瞻性队列研究,纳入芬兰、德国、瑞典和美国10145名1–8岁儿童,至少3次身高体重测量和至少1次胰岛自身抗体检测。
  • 主要结局为胰岛自身免疫的出现及从胰岛自身免疫进展为1型糖尿病。

主要发现

  • 身高快速增加(cm/年)与谷氨酸脱羧酶自身抗体、胰岛素自身抗体或胰岛素瘤样抗原-2自身抗体血清转换风险升高相关:1–3岁HR=1.26(95%CI 1.05,1.51),>3岁HR=1.48(95%CI 1.28,1.73)。
  • 从胰岛素自身抗体血清转换至糖尿病分析中,身高增长率与1型糖尿病发病正相关(HR=1.80,95%CI 1.15,2.81)。

局限性

  • 需要进一步研究以探讨可能解释该关联的生物学机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Rapid growth has been suggested to promote islet autoimmunity and progression to type 1 diabetes (T1D). Childhood growth has not been analyzed separately from the infant growth period in most previous studies, but it may have distinct features due to differences between the stages of development. OBJECTIVE: We aimed to analyze the association of childhood growth with development of islet autoimmunity and progression to T1D diagnosis in children 1 to 8 years of age. METHODS: Longitudinal data of childhood growth and development of islet autoimmunity and T1D were analyzed in a prospective cohort study including 10 145 children from Finland, Germany, Sweden, and the United States, 1-8 years of age with at least 3 height and weight measurements and at least 1 measurement of islet autoantibodies. The primary outcome was the appearance of islet autoimmunity and progression from islet autoimmunity to T1D. RESULTS: Rapid increase in height (cm/year) was associated with increased risk of seroconversion to glutamic acid decarboxylase autoantibody, insulin autoantibody, or insulinoma-like antigen-2 autoantibody (hazard ratio [HR] = 1.26 [95% CI = 1.05, 1.51] for 1-3 years of age and HR = 1.48 [95% CI = 1.28, 1.73] for >3 years of age). Furthermore, height rate was positively associated with development of T1D (HR = 1.80 [95% CI = 1.15, 2.81]) in the analyses from seroconversion with insulin autoantibody to diabetes. CONCLUSION: Rapid height growth rate in childhood is associated with increased risk of islet autoimmunity and progression to T1D. Further work is needed to investigate the biological mechanism that may explain this association.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li Z, Veijola R, Koski E, et al. Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 35244713. doi:10.1210/clinem/dgac121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。